$SBCF

SEACOAST BANKING CORP OF FLORIDA (SBCF): Results of Operations and Financial Condition

SEACOAST BANKING CORP OF FLORIDA (SBCF) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 sbcf2q2026earningsrelease.htm EX-99.1 SBCF 2Q 2026 Earnings Release SEACOAST REPORTS SECOND QUARTER 2026 RESULTS Strong Organic Loan Growth with Expanding Pipeline Well-Positioned Balance Sheet with Robust Capital and Liquidity STUART, Fla., July 28, 2026 /BUSINESS WIRE

Original reporting
Published Jul 28, 2026, 8:06 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 8:07 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$SBCF
Bullish
medium confidence
Mentioned
$SBCF
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SBCFBullishMed
01

Why it matters

Key disclosed drivers include sharply higher net income versus both prior quarter and prior year, 16% annualized organic loan growth, stable NIM at 3.83% (3.65% excluding accretion), and a decline in cost of deposits to 1.53%, alongside share repurchases.

02

Market read

Traders can update expectations for regional bank earnings power based on the combination of loan growth, deposit cost improvement, and stable NIM, plus ongoing buybacks.

03

What to watch

The excerpt does not include full asset quality metrics (e.g., NPLs, charge-offs, reserves) or any explicit forward guidance, which are key for banks and could offset the positive earnings drivers.

Relevance 7/10Novelty 8/10Timing: after-hours earnings release filed on 2026-07-28

Background

The company filed an SEC Form 8-K with its 2Q 2026 results of operations and financial condition, including a Business Wire earnings release exhibit.

Company-level read

Ticker impact

$SBCFBullishMedium confidence
Context

Seacoast Banking reported 2Q 2026 net income of $59.5M and $0.55/share, up 87% QoQ and 39% YoY, plus 16% annualized organic loan growth.

Expected impact

Likely positive bias for the stock into the next trading sessions as investors digest the earnings and deposit/NIM trajectory.

Evidence & confidence

This is a primary 8-K earnings release with multiple quantified drivers (net income, NII, NIM, cost of deposits, loan/deposit growth, buyback). However, the excerpt is truncated before full credit quality and guidance details, limiting precision on forward risk.

Market effects

Regional bank read-through: improving deposit costs and stable NIM support the broader narrative of easing funding pressure, though credit quality details are not fully visible in the excerpt.

Florida-focused franchise commentary (including The Villages) reinforces local growth expectations for community banks.

Limited global relevance; primarily a US regional bank earnings datapoint.

Counterpoint

The quarter’s strength may be partly influenced by prior-quarter securities repositioning and non-GAAP adjustments, so investors should verify sustainability of NIM and pre-provision earnings.

Key entities

  • Seacoast Banking Corporation of Florida

    NASDAQ-listed regional bank reporting 2Q 2026 earnings and balance sheet metrics in an 8-K.

Related articles

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.

$GXOMed

GXO Logistics Q2 Earnings Call Highlights

GXO Logistics reported Q2 results and said it secured over $1 billion in expected incremental new-business revenue for 2026 and about $353 million for 2027. Management cited a $2.7 billion sales pipeline after quarter end. Operating cash flow was $76 million, free cash flow positive $12 million, cash $769 million, and net leverage 2.6x. GXO plans to target EBIT margins above 6% and deploy AI across ~50 sites in 2026.

$GRNDMed

Grindr Q2 Earnings Call Highlights

Grindr (NYSE:GRND) said free users remain central to its strategy, while AI tools are boosting engineering productivity. Management estimated engineering output rose about 2.5x from July 2025 to April 2026 with similar headcount, supporting a 39% to 42% adjusted EBITDA margin outlook. EDGE AI premium tier rollout is planned for later in fall; operating expenses ex cost of revenue were $71M vs $53M.

$HAEMedAI 8/10

Haemonetics Q1 Earnings Call Highlights

Haemonetics (NYSE:HAE) reported Q1 interventional technologies returning to 3% organic growth, with vascular closure led by VASCADE MVP and MVP XL momentum in the U.S. Apheresis revenue rose 6% organically to $191M and plasma revenue grew 8% organically as Persona PLUS rollout accelerates. Haemonetics raised FY2027 revenue guidance to 5% to 8% reported and 4% to 7% organic.